CD79A and lymphopenia: Our data on the production of high levels of auto-/polyreactive IgA antibodies in response to lymphopenia-induced homeostatic B cell proliferation, particularly produced by FoB- and MZB-derived PCs, suggest that potential pathological effects could be conceivable for therapy-induced lymphopenia in humans.